Alaunos Therapeutics, Inc. Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate
Alaunos Therapeutics, Inc. (TCRT) reported Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate of 125.11% for the 3-month period ending 2025-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions and Methodology
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate · last filed 2026-08-14
- Alaunos Therapeutics, Inc. share-based compensation arrangement by share-based payment award, fair value assumptions, expected volatility rate for the quarter ending 2025-06-30 was 125.11%, a 26.62% decline year-over-year.
- Alaunos Therapeutics, Inc. share-based compensation arrangement by share-based payment award, fair value assumptions, expected volatility rate for the quarter ending 2025-03-31 was 113.26%, a 1.21% decline year-over-year.
- Alaunos Therapeutics, Inc. share-based compensation arrangement by share-based payment award, fair value assumptions, expected volatility rate for the quarter ending 2024-09-30 was 112.17%, a 23.74% increase year-over-year.
- Alaunos Therapeutics, Inc. share-based compensation arrangement by share-based payment award, fair value assumptions, expected volatility rate for the quarter ending 2024-06-30 was 170.50%.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate 3 month |
|---|---|
| 2025-06-30 | 125.11% 10-Q · filed 2026-08-14 |
| 2025-03-31 | 113.26% 10-Q · filed 2026-05-15 |
| 2024-09-30 | 112.17% 10-Q · filed 2025-11-14 |
| 2024-06-30 | 170.50% 10-Q · filed 2025-08-14 |
| 2024-03-31 | 114.65% 10-Q · filed 2025-05-15 |
| 2023-09-30 | 90.65% 10-Q · filed 2024-11-14 |
| 2021-06-30 | 74.08% 10-Q · filed 2022-08-15 |
| 2015-06-30 | 85.57% 10-Q · filed 2016-08-09 |
| 2014-09-30 | 92.36% 10-Q · filed 2015-11-02 |
| 2014-06-30 | 94.07% 10-Q · filed 2015-08-10 |
| 2013-06-30 | 95.45% 10-Q · filed 2014-08-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| Sunshine Biopharma Inc. (SBFM) | $0.003B | ||
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Aptevo Therapeutics Inc. (APVO) | United States | $0.003B | |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |